Corporate & Milestones

  

20
Feb
2024

Kisolite’s Regulatory Pathway

by Kisolite Corp. February 20th, 2024 in Corporate & Milestones
Kisolite Corp receives feedback from FDA Center for Drug Evaluation and Research (CDER) stating that Kisolite API should be an over-the-counter (OTC) drug.
Read More
10
Dec
2023

Member at Life Sciences BC

by Kisolite Corp. December 10th, 2023 in Corporate & Milestones
Kisolite Corp becomes a member at Life Sciences BC.
Read More
01
Nov
2023

Member at BioteCanada

by Kisolite Corp. November 1st, 2023 in Corporate & Milestones
Kisolite Corp becomes a member at BioteCanada.
Read More